Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.668
-0.052 (-3.02%)
Nov 21, 2024, 11:39 AM EST - Market open
Accelerate Diagnostics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 39 | 57 | 70 | 364 | 432 | 923 | |
Market Cap Growth | -50.99% | -18.47% | -80.76% | -15.88% | -53.19% | 48.46% | |
Enterprise Value | 78 | 72 | 91 | 420 | 502 | 933 | |
Last Close Price | 1.70 | 3.92 | 7.06 | 52.20 | 75.80 | 169.00 | |
PS Ratio | 2.95 | 4.73 | 5.49 | 30.86 | 38.72 | 99.33 | |
PB Ratio | -0.84 | -2.87 | -3.14 | -10.37 | -6.88 | -125.15 | |
EV/Sales Ratio | 6.58 | 6.01 | 7.17 | 35.68 | 44.99 | 100.34 | |
Debt / Equity Ratio | -1.22 | -1.97 | -3.48 | -3.17 | -2.39 | -18.17 | |
Asset Turnover | 0.33 | 0.25 | 0.17 | 0.13 | 0.10 | 0.06 | |
Inventory Turnover | 2.76 | 2.24 | 1.84 | 1.70 | 0.78 | 0.62 | |
Quick Ratio | 1.26 | 1.32 | 0.72 | 9.49 | 10.02 | 13.68 | |
Current Ratio | 1.50 | 2.03 | 0.84 | 10.56 | 11.76 | 14.93 | |
Return on Equity (ROE) | - | - | - | - | - | -337.25% | |
Return on Assets (ROA) | -66.49% | -70.07% | -53.02% | -50.69% | -34.73% | -28.48% | |
Return on Capital (ROIC) | -395.97% | -90.52% | -59.78% | -54.81% | -37.00% | -29.93% | |
Earnings Yield | -136.81% | -108.03% | -89.32% | -21.37% | -18.09% | -9.13% | |
FCF Yield | -70.38% | -72.29% | -70.44% | -13.18% | -11.97% | -7.05% | |
Buyback Yield / Dilution | -83.18% | -51.86% | -33.10% | -10.21% | -2.76% | -0.02% | |
Total Shareholder Return | -83.18% | -51.86% | -33.10% | -10.21% | -2.76% | -0.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.